Session Information
Free - CMES03 - Individualizing Diabetes Treatment for Improved Glycemic Control and Management of Comorbidities
Click here to go to the previous page
Pathophysiology of Type 2 Diabetes and the Incretin Pathway
Program Code:
CMES03-2
Date:
Sunday, June 5, 2011
Time:
7:15 PM to 7:50 PM
EST
Location:
Renaissance, Pacific Ballroom DEFGH
SPEAKER
:
Adrian Vella, MD, MRCP, Mayo Clinic
Disclosure: Research grant recipient, Daiichi Sankyo, Merck & Co.
Disclosure: Research grant recipient, Daiichi Sankyo, Merck & Co.
Audio Synchronized to PowerPoint
